Iisrael - inglise - Ministry of Health

rafa laboratories ltd - fentanyl - patches - fentanyl 12.5 mcg/hour - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.

Iisrael - inglise - Ministry of Health

rafa laboratories ltd - fentanyl - patches - fentanyl 25 mcg/hour - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.

Iisrael - inglise - Ministry of Health

rafa laboratories ltd - fentanyl - patches - fentanyl 50 mcg/hour - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.

Iisrael - inglise - Ministry of Health

rafa laboratories ltd - fentanyl - patches - fentanyl 75 mcg/hour - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.

Singapur - inglise - HSA (Health Sciences Authority)

mediwell enterprise pte ltd - clinical toxicology - a lateral flow chromatographic immunoassay for the detection of oxazepam (major metabolite) in urine at a cut-off concentration of 300ng/ml. this test will detect other benzodiazepines, please refer to the analytical specificity table in this package insert.

Singapur - inglise - HSA (Health Sciences Authority)

beckman coulter singapore pte. ltd. - clinical chemistry - homogeneous enzyme immunoassay for the qualitative and semi-quantitative assay of benzodiazepines in human urine on beckman coulter au analysers. for in vitro diagnostic use only.the assay provides only a preliminary analytical test result. a more specific alternative chemical method must be used to obtain a confirmed analytical result. gas chromatography/mass spectrometry (gc/ms) is the preferred confirmatory method. clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when using a preliminary positive result.

Singapur - inglise - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - clinical toxicology - roche diagnostics cobas integra benzodiazepines ii (bnzii) is an in vitro diagnostic test for the semiquantitative and qualitative detection of benzodiazepines in human urine at cutoff concentrations of 100, 200, and 300 ng/ml on cobas integra systems

Singapur - inglise - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - clinical toxicology - roche diagnostics cobas integra serum benzodiazepines (sbenz) is an in vitro diagnostic test for the detection of benzodiazepines and their metabolites in human serum, heparinized plasma, or urine on cobas integra systems

Singapur - inglise - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clinical toxicology - the alinity c benzodiazepines assay is a homogeneous enzyme immunoassay intended for the qualitative and/or semiquantitative determination of the presence of benzodiazepines and their metabolites in human urine at a cutoff concentration of 200 ng/ml (0.700 μmol/l) on the alinity c analyzer.

Singapur - inglise - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clinical toxicology - the alinity c serum benzodiazepines assay is used for the qualitative and semiquantitative determination of benzodiazepines in human serum or plasma with a 50 ng/ml cutoff on the alinity c analyzer.